BD & licensing diligence
Asset diligence in days, not months.
From the first NDA to the term sheet, Knowledgeable maps the target's clinical position, competitor landscape, HTA precedent, pricing corridor and deal comparables, so your BD team is asking the right questions on call two, not call seven.
Watch it run on your work.
Where this fits in your workflow.
From the first NDA to the term sheet, Knowledgeable maps the target's clinical position, competitor landscape, HTA precedent, pricing corridor and deal comparables, so your BD team is asking the right questions on call two, not call seven.
Most teams running BD · Licensing today juggle a stack of search tools, PDF readers and consultancy slides, then spend the back half of the project reconciling claims to sources. Knowledgeable collapses that into one defensible workflow: asset diligence in days, not months.
The work runs against your literature, trial registries, HTA precedent, label and SmPC, with every sentence pinpoint-cited so your senior reviewer opens a document that's already at QC.
- 1Scope & comparator locked
- 2Evidence pulled & graded
- 3Draft built with citations
- 4QC pass against framework
The work that finally lands the way you scoped it.
Asset-level, not company-level
Diligence on the specific asset and indication, not a generic 'company brief'.
Competitor and pipeline aware
What else is moving in the indication, what's likely to launch first, what the label race looks like.
Deal comparables
Recent licensing deals at the relevant phase, with structure, valuation logic and risk-sharing benchmarks.
Every claim sourced
Term sheet defensible. Audit trail intact. No 'where did we get that?' in negotiation.
Close on the right asset, at the right number.
Scope a diligenceMore for commercial & strategy teams.
Built for BD-grade scrutiny.
Sourced, audit-trailed, version-controlled. Holds up to legal, finance and the board.